Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma.
Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma. — المؤلف: Kudo, Masatoshi — Liver cancer Oct 2018
- المؤلف
- Kudo, Masatoshi
- النشر
- Liver cancer Oct 2018
- الوصف
- 305-311 p.